Google
Trusted Resources: Education
Scientific literature and patient education texts
AA Amyloidosis
source: Cleveland Clinic
year: 2022
summary/abstract:AA amyloidosis, or secondary amyloidosis, is one type of the rare disorder amyloidosis. This disorder happens when proteins in your body mutate, changing form and gathering on your organs and tissues. AA amyloidosis happens because you have a chronic inflammatory condition or disease. Healthcare providers treat AA amyloidosis by controlling the underlying disease or condition.
read more
myBinderRelated Content
-
Emerging Advances in the Management of Cardiac AmyloidosisAmyloidosis is a disease in which protei...
-
Association of Black CardiologistsFounded in 1974, the Association of Blac...
-
From older to younger: intergenerational promotion of health behaviours in Portuguese families affected by familial ...The role of older generations in familie...
-
Long-term survival in people with transthyretin amyloid cardiomyopathy who took tafamidis: a plain language summaryWhat is this plain language summary abou...
-
ISA 2020 | 99mTc-DPD Scintigraphy Predicts Amyloid Fibril Type in ATTR Amyloidosishttps://www.youtube.com/watch?v=losWZBVV...
-
Hereditary ATTR Thr60Ala AmyloidosisHereditary ATTR amyloidosis is an inheri...
-
Nutrition Guidelines for Patients: Hereditary Transthyretin Amyloidosis (Spanish)Adopting simple, healthy habits is one o...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Community Key Collaborator
Support for this landing page is provided by an independent education grant from
Translation of this platform made possible through an independent education grant from
Powered by
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
